Sesen Bio, Inc. and Carisma Therapeutics Inc., a privately-held, clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced an amendment to...
EnfraGen, LLC, a developer, owner, and operator of specialized sustainable, renewable power and grid stability assets in Latin America owned by Glenfarne Energy Transition,...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced the initiation of a Phase 2 trial...
